Back to Search
Start Over
Long-term methotrexate for Crohn's disease: safety and efficacy in clinical practice
- Source :
- Journal of clinical gastroenterology. 42(4)
- Publication Year :
- 2008
-
Abstract
- Goals: To assess the efficacy and safety profile of methotrexate (MTX) for the treatment of Crohn's disease (CD) in clinical practice. Background: MTX is widely used for some chronic immunologic diseases. Although some randomized controlled trials suggest its efficacy in CD, this drug remains a second-line, underused, immunomodulator. Study: Medical records of all patients treated with MTX for CD in our center (n = 44) were reviewed. Clinical and epidemiologic parameters, including risk factors for hepatotoxicity, were registered. Results: MTX was prescribed mainly for steroid-dependency (n = 22) and as concomitant treatment to infliximab (n = 18). Mean duration of treatment was 22.9 ± 19 months, with a mean cumulative dose of MTX of 1169 ± 784 mg. Thirty-nine percent of patients developed drug-related side effects, hepatotoxicity being the most frequent [13 patients (30%)]. However, only 5 patients (11%) had to discontinue MTX. In steroid-dependent CD patients, disease remission and complete steroid withdrawal was achieved in 77% of cases. Seven patients lost their initial response to MTX during follow-up, leading to a cumulative probability of remission of 39% after 3 years of treatment. Conclusions: MTX is well tolerated in most CD patients. Although a great proportion of steroid-dependent CD patients achieve disease remission and steroid withdrawal, there is a trend to a loss of efficacy with time. Larger, long-term studies are necessary to establish the role of MTX in the management of CD.
- Subjects :
- musculoskeletal diseases
Adult
Male
medicine.medical_specialty
Time Factors
Adolescent
Inflammatory bowel disease
Gastroenterology
law.invention
Randomized controlled trial
Crohn Disease
law
Risk Factors
Internal medicine
Medicine
Humans
Crohn's disease
Dose-Response Relationship, Drug
Cumulative dose
business.industry
Drug Administration Routes
Middle Aged
medicine.disease
Ulcerative colitis
Infliximab
Surgery
Methotrexate
Treatment Outcome
Concomitant
Female
business
Immunosuppressive Agents
medicine.drug
Follow-Up Studies
Subjects
Details
- ISSN :
- 01920790
- Volume :
- 42
- Issue :
- 4
- Database :
- OpenAIRE
- Journal :
- Journal of clinical gastroenterology
- Accession number :
- edsair.doi.dedup.....f91ad5dc0c69ec87a9b41c20bbc427f4